3 results
Approved WMOCompleted
Primary objective:To evaluate the safety and tolerability of KY1005.Secondary objectives:To evaluate the pharmacokinetics (PK) of KY1005 following single and repeat doses.Exploratory objectives:- To evaluate the immunogenicity of KY1005;- To assess…
Approved WMOPending
To evaluate the efficacy of crovalimab compared to eculizumab
Approved WMOPending
To evaluate the safety and tolerability of crovalimab compared witheculizumab